These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
108 related articles for article (PubMed ID: 1926673)
1. [Post-ischemia normal function of living related kidney transplants after preservation with HTK solution]. Vieweg J; Heidecke CD; Beckurts T; Hölscher M Urologe A; 1991 Jul; 30(4):256-9. PubMed ID: 1926673 [TBL] [Abstract][Full Text] [Related]
3. Comparison of histidine-tryptophan ketoglutarate and University of Wisconsin solutions as primary preservation in renal allografts undergoing pulsatile perfusion. Agarwal A; Goggins WC; Pescovitz MD; Milgrom ML; Murdock P; Fridell JA Transplant Proc; 2005 Jun; 37(5):2016-9. PubMed ID: 15964327 [TBL] [Abstract][Full Text] [Related]
4. Kidney transplantation from non-heart-beating donors after oxygenated low-flow machine perfusion preservation with histidine-tryptophan-ketoglutarate solution. Minor T; Sitzia M; Dombrowski F Transpl Int; 2005 Jan; 17(11):707-12. PubMed ID: 15717215 [TBL] [Abstract][Full Text] [Related]
5. Kidney procurement with the HTK solution of Bretschneider. Isemer FE; Ludwig A; Schunck O; Bretschneider HJ; Peiper HJ Transplant Proc; 1988 Oct; 20(5):885-6. PubMed ID: 3142122 [No Abstract] [Full Text] [Related]
6. Comparison of histidine-tryptophan ketoglutarate solution and University of Wisconsin solution in prolonged cold preservation of kidney allografts. Agarwal A; Murdock P; Fridell JA Transplantation; 2006 Feb; 81(3):480-2. PubMed ID: 16477239 [TBL] [Abstract][Full Text] [Related]
7. [Kidney function parameters following ischemia stress using the Euro-Collins solution or the Bretschneider cardioplegic HTK solution]. Kallerhoff M; Blech M; Kehrer G; Kleinert H; Langheinrich M; Siekmann W; Helmchen U; Bretschneider HJ Urologe A; 1987 Mar; 26(2):96-103. PubMed ID: 3109096 [TBL] [Abstract][Full Text] [Related]
9. Safety and efficacy of living donor liver preservation with HTK solution. Ringe B; Braun F; Moritz M; Zeldin G; Soriano H; Meyers W Transplant Proc; 2005; 37(1):316-9. PubMed ID: 15808629 [TBL] [Abstract][Full Text] [Related]
10. Preservation of canine liver grafts using HTK solution. van Gulik TM; Reinders ME; Nio R; Frederiks WM; Bosma A; Klopper PJ Transplantation; 1994 Jan; 57(2):167-71. PubMed ID: 8310502 [TBL] [Abstract][Full Text] [Related]
11. Improved renal function of warm ischemically damaged kidneys using Polysol. Schreinemachers MC; Doorschodt BM; Florquin S; Idu MM; Tolba RH; van Gulik TM Transplant Proc; 2009; 41(1):32-5. PubMed ID: 19249468 [TBL] [Abstract][Full Text] [Related]
12. Oxygenated machine perfusion preservation of predamaged kidneys with HTK and Belzer machine perfusion solution: an experimental study in pigs. Manekeller S; Leuvenink H; Sitzia M; Minor T Transplant Proc; 2005 Oct; 37(8):3274-5. PubMed ID: 16298570 [TBL] [Abstract][Full Text] [Related]
13. Preliminary results of a clinical randomized study comparing Celsior and HTK solutions in liver preservation for transplantation. Nardo B; Bertelli R; Montalti R; Beltempo P; Puviani L; Pacilè V; Cavallari A Transplant Proc; 2005; 37(1):320-2. PubMed ID: 15808630 [TBL] [Abstract][Full Text] [Related]
14. [Continuous in situ cold perfusion with HTK solution in conservative surgery of kidney tumor]. de Petriconi R; Gschwend JE; Maier S; Hautmann RE Urologe A; 1995 Nov; 34(6):449-56. PubMed ID: 8848855 [TBL] [Abstract][Full Text] [Related]
15. Organ preservation with histidine-tryptophan ketogluatarate solution in clinical pancreas transplantation: an update of the indiana university experience. Agarwal A; Powelson JA; Goggins WC; Milgrom ML; Fridell JA Transplant Proc; 2008 Mar; 40(2):498-501. PubMed ID: 18374113 [TBL] [Abstract][Full Text] [Related]
16. Current status of the Eurotransplant randomized multicenter study comparing kidney graft preservation with histidine-tryptophan-ketogluterate, University of Wisconsin, and Euro-Collins solutions. The HTK Study Group. Groenewoud AF; Thorogood J Transplant Proc; 1993 Feb; 25(1 Pt 2):1582-5. PubMed ID: 8442198 [No Abstract] [Full Text] [Related]
17. Microscopic intrarenal particles after pulsatile machine preservation do not adversely affect outcomes after renal transplantation. Guarrera JV; Nasr SH; Reverte CM; Samstein B; Brown T; Balachandran V; Samuels MJ; Kelly J; Hardy MA; Markowitz GS; D'Agati VD; Ratner LE Transplant Proc; 2006 Dec; 38(10):3384-7. PubMed ID: 17175278 [TBL] [Abstract][Full Text] [Related]
18. A preliminary report of the HTK randomized multicenter study comparing kidney graft preservation with HTK and EuroCollins solutions. HTK Study Group. Groenewoud AF; Thorogood J Transpl Int; 1992; 5 Suppl 1():S429-32. PubMed ID: 14628738 [TBL] [Abstract][Full Text] [Related]
19. The use of oxygenated perfluorocarbonic emulsion for initial in situ kidney perfusion. Reznik ON; Bagnenko SF; Loginov IV; Iljina VA; Ananyev AN; Moysyuk YG Transplant Proc; 2008 May; 40(4):1027-8. PubMed ID: 18555106 [TBL] [Abstract][Full Text] [Related]
20. Renal allograft preservation: a comparison of University of Wisconsin solution and of hypothermic continuous pulsatile perfusion. Veller MG; Botha JR; Britz RS; Gecelter GR; Beale PG; Margolius LP; Meyers KE; Thompson PD; Meyers AM; Myburgh JA Clin Transplant; 1994 Apr; 8(2 Pt 1):97-100. PubMed ID: 8019029 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]